Invitrogen Launches Vector NTI(R) Advance(TM) 10; Release Includes Vector NTI(R) Open Access Policy and Vector NTI(R) User Community to Drive Life Science Standardization

Invitrogen Corporation, a leading life sciences company with a broad portfolio of technologies to improve and accelerate biomedical research, drug discovery and commercial bioproduction, today announced the release of its latest technology and eScience contribution to the life sciences, Vector NTI Advance(TM) 10.

Please to read the entire article.